1.Alternative Name:Leu-1;Leu-1;CD5 antigen (p56-62); CD5 antigen; CD5 molecule; CD5; LEU1T-cell surface glycoprotein CD5; Lymphocyte antigen T1/Leu-1; T1
2.Target:CD5
3.Source:Human CD5 was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Arg25-Pro372
5.Protein structure:P06127His
6.Molecular Characterization:The protein has a calculated MW of 64kDa.The reducing (R) heterodimer protein migrates as 70-90 kDa due to glycosylation
7.Purity:SDS-PAGE>95%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA

When Recombinant Human CD5/hFC Protein is immobilized at 5μg/mL (100 μL/well), the concentration of Anti-Human CD5 (hIgG1-LALAPG) that produces 50% of the optimal binding response is approximately 70 ng/ml.